Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea


Acne rosacea is an inflammatory skin disease that affects 3% of the US population over 30 years of age and is characterized by erythema, papulopustules and telangiectasia1,2,3. The etiology of this disorder is unknown, although symptoms are exacerbated by factors that trigger innate immune responses, such as the release of cathelicidin antimicrobial peptides4. Here we show that individuals with rosacea express abnormally high levels of cathelicidin in their facial skin and that the proteolytically processed forms of cathelicidin peptides found in rosacea are different from those present in normal individuals. These cathelicidin peptides are a result of a post-translational processing abnormality associated with an increase in stratum corneum tryptic enzyme (SCTE) in the epidermis. In mice, injection of the cathelicidin peptides found in rosacea, addition of SCTE, and increasing protease activity by targeted deletion of the serine protease inhibitor gene Spink5 each increases inflammation in mouse skin. The role of cathelicidin in enabling SCTE-mediated inflammation is verified in mice with a targeted deletion of Camp, the gene encoding cathelicidin. These findings confirm the role of cathelicidin in skin inflammatory responses and suggest an explanation for the pathogenesis of rosacea by demonstrating that an exacerbated innate immune response can reproduce elements of this disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Cathelicidin is abundant in rosacea.
Figure 2: Altered expression of cathelicidin peptides in rosacea skin.
Figure 3: Increased SCTE expression and protease activity in rosacea epidermis.
Figure 4: Cathelicidin peptides augment cytokine induction in human keratinocytes and skin inflammation.

Similar content being viewed by others


  1. Kelly, A.P. Acne and related disorders. in Principles and Practice of Dermatology (eds. Sams, W. & Lynch, P.) 801–818 (Churchill Livingstone, New York, 1996).

    Google Scholar 

  2. Straus, J. Rosacea and acne rosacea. in Dermatology (eds. Orkin, M., Maibach, H. & Dahl, M.) 337–338 (Prentice Hall International Inc., New Jersey, 1991).

    Google Scholar 

  3. Crawford, G.H., Pelle, M.T. & James, W.D. Rosacea: I. Etiology, pathogenesis, and subtype classification. J. Am. Acad. Dermatol. 51, 327–341 quiz 342–344 (2004).

    Article  Google Scholar 

  4. Zanetti, M. The role of cathelicidins in the innate host defenses of mammals. Curr. Issues Mol. Biol. 7, 179–196 (2005).

    CAS  PubMed  Google Scholar 

  5. Zanetti, M. Cathelicidins, multifunctional peptides of the innate immunity. J. Leukoc. Biol. 75, 39–48 (2004).

    Article  Google Scholar 

  6. van Dijk, A., Veldhuizen, E.J., van Asten, A.J. & Haagsman, H.P. CMAP27, a novel chicken cathelicidin-like antimicrobial protein. Vet. Immunol. Immunopathol. 106, 321–327 (2005).

    Article  CAS  Google Scholar 

  7. Chang, C.I., Pleguezuelos, O., Zhang, Y.A., Zou, J. & Secombes, C.J. Identification of a novel cathelicidin gene in the rainbow trout, Oncorhynchus mykiss. Infect. Immun. 73, 5053–5064 (2005).

    Article  CAS  Google Scholar 

  8. Nizet, V. et al. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414, 454–457 (2001).

    Article  CAS  Google Scholar 

  9. Rosenberger, C.M., Gallo, R.L. & Finlay, B.B. Interplay between antibacterial effectors: a macrophage antimicrobial peptide impairs intracellular Salmonella replication. Proc. Natl. Acad. Sci. USA 101, 2422–2427 (2004).

    Article  CAS  Google Scholar 

  10. Iimura, M. et al. Cathelicidin mediates innate intestinal defense against colonization with epithelial adherent bacterial pathogens. J. Immunol. 174, 4901–4907 (2005).

    Article  CAS  Google Scholar 

  11. Howell, M.D. et al. Selective killing of vaccinia virus by LL-37: implications for eczema vaccinatum. J. Immunol. 172, 1763–1767 (2004).

    Article  CAS  Google Scholar 

  12. Ong, P.Y. et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med. 347, 1151–1160 (2002).

    Article  CAS  Google Scholar 

  13. Oppenheim, J.J. & Yang, D. Alarmins: chemotactic activators of immune responses. Curr. Opin. Immunol. 17, 359–365 (2005).

    Article  CAS  Google Scholar 

  14. De, Y. et al. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J. Exp. Med. 192, 1069–1074 (2000)[AG1].

    Article  Google Scholar 

  15. Koczulla, R. et al. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J. Clin. Invest. 111, 1665–1672 (2003).

    Article  CAS  Google Scholar 

  16. Gallo, R.L. et al. Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds. Proc. Natl. Acad. Sci. USA 91, 11035–11039 (1994).

    Article  CAS  Google Scholar 

  17. Frohm, M. et al. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J. Biol. Chem. 272, 15258–15263 (1997).

    Article  CAS  Google Scholar 

  18. Heilborn, J.D. et al. The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J. Invest. Dermatol. 120, 379–389 (2003).

    Article  CAS  Google Scholar 

  19. Zaiou, M., Nizet, V. & Gallo, R.L. Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence. J. Invest. Dermatol. 120, 810–816 (2003).

    Article  CAS  Google Scholar 

  20. Braff, M.H. et al. Structure-function relationships among human cathelicidin peptides: dissociation of antimicrobial properties from host immunostimulatory activities. J. Immunol. 174, 4271–4278 (2005).

    Article  CAS  Google Scholar 

  21. Yamasaki, K. et al. Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicdiins in skin. FASEB J. 20, 2068–2080 (2006).

    Article  CAS  Google Scholar 

  22. Murakami, M., Lopez-Garcia, B., Braff, M., Dorschner, R.A. & Gallo, R.L. Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense. J. Immunol. 172, 3070–3077 (2004).

    Article  CAS  Google Scholar 

  23. Descargues, P. et al. Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity. Nat. Genet. 37, 56–65 (2005).

    Article  CAS  Google Scholar 

  24. Gallo, R.L. et al. Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse. J. Biol. Chem. 272, 13088–13093 (1997).

    Article  CAS  Google Scholar 

  25. Komatsu, N. et al. Quantification of human tissue kallikreins in the stratum corneum: dependence on age and gender. J. Invest. Dermatol. 125, 1182–1189 (2005).

    Article  CAS  Google Scholar 

  26. Dorschner, R.A. et al. Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J. Invest. Dermatol. 117, 91–97 (2001).

    Article  CAS  Google Scholar 

  27. Acharya, M.R., Venitz, J., Figg, W.D. & Sparreboom, A. Chemically modified tetracyclines as inhibitors of matrix metalloproteinases. Drug Resist. Updat. 7, 195–208 (2004).

    Article  Google Scholar 

  28. Hansson, L. et al. Epidermal overexpression of stratum corneum chymotryptic enzyme in mice: a model for chronic itchy dermatitis. J. Invest. Dermatol. 118, 444–449 (2002).

    Article  CAS  Google Scholar 

  29. Brinnel, H., Friedel, J., Caputa, M., Cabanac, M. & Grosshans, E. Rosacea: disturbed defense against brain overheating. Arch. Dermatol. Res. 281, 66–72 (1989).

    Article  CAS  Google Scholar 

  30. Murakami, M. et al. Cathelicidin anti-microbial peptide expression in sweat, an innate defense system for the skin. J. Invest. Dermatol. 119, 1090–1095 (2002).

    Article  CAS  Google Scholar 

Download references


We thank B. Cottrell for instructions in SELDI-TOF-MS analysis. This work was supported by the National Institutes of Health (R01-AI052453, R01-AR45676), The National Rosacea Society and a VA Merit Award (R.L.G.); and the Association for Preventive Medicine of Japan (K.Y.).

Author information

Authors and Affiliations



K.Y. conducted SELDI-TOF-MS experiments, protease assays including in situ zymography and in vivo studies, and wrote the manuscript. A.D.N. conducted the in vivo skin irritation model. A.B., M.M. and T.O. performed immunohistochemistry, dot blot and in situ hybridization. A.C. performed immunofluorescence. R.A.D. prepared and purified peptides. C.B., P.D. and A.H. contributed to the experiments with Spink5-deficient mice. A.B., V.B.M. and R.L.G. organized human sample collection. R.L.G. conceived, designed and supervised all aspects of this work.

Corresponding author

Correspondence to Richard L Gallo.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Text and Figures

Supplementary Figs. 1–4, Supplementary Methods (PDF 886 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yamasaki, K., Di Nardo, A., Bardan, A. et al. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med 13, 975–980 (2007).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing